ČERMÁK, Aleš, Natália MAREČKOVÁ, Kamila KARMAŠOVÁ and Dalibor PACÍK. Antibiotic resistence changes in infection following transrectal ultrasound guided prostate biopsy - review of 5 years period. European Urology Supplements. Elsevier B.V., 2010, 9/2010, No 2, p. 82-83. ISSN 1569-9056.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Antibiotic resistence changes in infection following transrectal ultrasound guided prostate biopsy - review of 5 years period
Name (in English) Antibiotic resistence changes in infection following transrectal ultrasound guided prostate biopsy - review of 5 years period
Authors ČERMÁK, Aleš (203 Czech Republic, guarantor, belonging to the institution), Natália MAREČKOVÁ (703 Slovakia, belonging to the institution), Kamila KARMAŠOVÁ (203 Czech Republic, belonging to the institution) and Dalibor PACÍK (203 Czech Republic, belonging to the institution).
Edition European Urology Supplements, Elsevier B.V. 2010, 1569-9056.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.139
RIV identification code RIV/00216224:14110/10:00046964
Organization unit Faculty of Medicine
Keywords in English prostate cancer infectious complications antibiotic therapy antibiotic resistence
Changed by Changed by: MUDr. Vítězslav Vít, učo 51. Changed: 19/1/2011 21:54.
Abstract
The authors did not observe an increase in the incidence of infectious complications following PB in past five years. Our standard antibiotic prophylaxis with fluorochinolone + metronidazol has proved to be still effective in more than 97% of PBs.On the other hand, in cases of failed prophylaxis, we noticed a substantial increase in the antibiotic resistance to the commonly used antibiotics. This should lead us to an aggressive treatment and early administration of wide spectrum antibiotics in patients suffering serious septic complications (meropenem,ceftazidime, tazobactam + ticarcilin).
Abstract (in English)
The authors did not observe an increase in the incidence of infectious complications following PB in past five years. Our standard antibiotic prophylaxis with fluorochinolone + metronidazol has proved to be still effective in more than 97% of PBs.On the other hand, in cases of failed prophylaxis, we noticed a substantial increase in the antibiotic resistance to the commonly used antibiotics. This should lead us to an aggressive treatment and early administration of wide spectrum antibiotics in patients suffering serious septic complications (meropenem,ceftazidime, tazobactam + ticarcilin).
PrintDisplayed: 31/8/2024 02:32